Your browser doesn't support javascript.
loading
Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies.
Xue, Busheng; Zhao, Jiansong; Feng, Penghui; Xing, Jia; Wu, Hongliang; Li, Yan.
Afiliação
  • Xue B; Department of Spine and Joint Surgery, Shengjing Hospital, China Medical University, Shenyang, People's Republic of China, liy15@sj-hospital.org.
  • Zhao J; Department of Spine and Joint Surgery, Shengjing Hospital, China Medical University, Shenyang, People's Republic of China, liy15@sj-hospital.org.
  • Feng P; Department of Obstetrics and Gynecology-Reproductive Medical Center, Shengjing Hospital, China Medical University, Shenyang, People's Republic of China.
  • Xing J; Department of Histology and Embryology, Basic Medicine College, China Medical University, Shenyang, People's Republic of China.
  • Wu H; Department of Spine and Joint Surgery, Shengjing Hospital, China Medical University, Shenyang, People's Republic of China, liy15@sj-hospital.org.
  • Li Y; Department of Spine and Joint Surgery, Shengjing Hospital, China Medical University, Shenyang, People's Republic of China, liy15@sj-hospital.org.
Onco Targets Ther ; 12: 549-559, 2019.
Article em En | MEDLINE | ID: mdl-30666134
ABSTRACT
Ubiquitin-like with plant homeodomain and really interesting new gene finger domains 1 (UHRF1) functions as an epigenetic regulator recruiting PCNA, DNMT1, histone deacetylase 1, G9a, SuV39H, herpes virus-associated ubiquitin-specific protease, and Tat-interactive protein by multiple corresponding domains of DNA and H3 to maintain DNA methylation and histone modifications. Overexpression of UHRF1 has been found as a potential biomarker in various cancers resulting in either DNA hypermethylation or global DNA hypo-methylation, which participates in the occurrence, progression, and invasion of cancer. The role of UHRF1 in the reciprocal interaction between DNA methylation and histone modifications, the dynamic structural transformation of UHRF1 protein within epigenetic code replication machinery in epigenetic regulations, as well as modifications during cell cycle and chemotherapy targeting UHRF1 are evaluated in this study.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article